Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from dorsaVi Limited ( (AU:DVL) ) is now available.
dorsaVi Limited has reported significant growth in the US Physical Therapy market with its ViMove+ product, achieving a 15-fold increase in monthly acquisition trends. The company’s strategic expansion, including successful face-to-face training sessions in Arizona, has resulted in a 90% conversion rate, indicating strong demand and validating their rollout strategy. This growth is supported by the adoption of their products by US surgeons and the development of a hardware roadmap incorporating advanced technology, positioning dorsaVi for continued success in a lucrative and expanding market.
More about dorsaVi Limited
dorsaVi Limited operates in the healthcare industry, focusing on providing motion analysis tools. Their primary product, ViMove+, is designed to empower clinicians, surgeons, and physicians with data-informed decision-making capabilities. The company targets the US Physical Therapy market, leveraging its products’ success with professional sports teams to enhance its market positioning.
Average Trading Volume: 8,296,206
Technical Sentiment Signal: Hold
Current Market Cap: A$66.4M
See more insights into DVL stock on TipRanks’ Stock Analysis page.